About Bluestem Capital
Bluestem Capital is a private equity firm founded in 1989. It is primarily based in Sioux Falls, United States.
Overall Bluestem Capital portfolio has seen 1 IPO and 6 acquisitions, namely Shoulder Innovations, SpringCM and Tear Film Innovations. A lot of funds co-invest with Bluestem Capital, with names like Visionary Ventures sharing a substantial percentage of its portfolio.
Bluestem Capital has a team of 6 people, including 3 partners.
Key Metrics
Bluestem Capital's Portfolio
They have invested in a total of 37 companies. Their most recent investment was in Orasis Pharmaceuticals (Series D round) on Oct 08, 2024. Here is the most recent investment by Bluestem Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Oct 08, 2024 | Series D | 3704 | ||
Oct 25, 2023 | Series A | 9586 | ||
Jun 28, 2023 | Series C | 5192 | ||
Sep 01, 2022 | Series E | 7569 |
Here is the portfolio snapshot of Bluestem Capital:
Investments by Year
The maximum number of investments were made in 2017
Team profile of Bluestem Capital
Bluestem Capital has a team of 6 members including 3 Partners and 1 Principal located in United States. Bluestem Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Bluestem Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Sioux Falls | - | ||
Partner | Sioux Falls | - | ||
Partner | United States | - | ||
Principal | Sioux Falls | - |
Co-investors of Bluestem Capital
Over the past 37 years, 30 investors have co-invested in Bluestem Capital's portfolio companies.
- Top Co-investors of Bluestem Capital: 30 investors entered a company along with Bluestem Capital. These include investors like Visionary Ventures (2 companies).
Bluestem Capital News
•
•
Lentechs completes USD 6M fundraise led by Vision VestmentsMedical Buyer•Oct 25, 2023•Lentechs, JobsOhio, Ohio Innovation Fund, Bluestem Capital and 1 other
•
Virtual Incision Raises $30 Million in Series C Funding ExtensionSilicon Valley Journals•Sep 19, 2023•Virtual Incision, Bluestem Capital, Endeavour Vision, Baird Capital and 4 others
•
Neurolens Completes $67 Million in New FinancingVision Monday•Sep 13, 2022•Neurolens, MVM, Falcon-Vision, Marshall Wace and 1 other
•
Neurolens Raises $67M in FundingFinSMEs•Sep 12, 2022•Neurolens, MVM, Falcon-Vision, Marshall Wace and 2 others
•
Virtual Incision Gains $45M to Advance MIRA Mini-Surgical Robotics PlatformMedical Product Outsourcing•Nov 30, 2021•Endeavour Vision, Baird Capital, Virtual Incision, Bluestem Capital and 1 other
•
Zerigo Health Raises $43M in Series B FundingFinSMEs•Oct 21, 2021•Zerigo Health, 7wire Ventures, General Catalyst, Dragoneer Investment Group and 7 others
•
Sydnexis Secures $45 Million Series B FinancingEyewire•Aug 10, 2021•Longitude Capital, Medicxi, RA Capital Management, SC Master Fund and 3 others
•
Orasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for PresbyopiaGlobeNewswire•Sep 10, 2020•Orasis Pharmaceuticals, Bluestem Capital, Visionary Ventures, Sequoia Capital and 4 others
•
TearClear Raises $22 Million to Advance Multiple Clinical Programs in DevelopmentGlobeNewswire•Aug 11, 2020•TearClear, Visionary Ventures, Bluestem Capital, Flying L Partners and 1 other